Since its debut in 2012, CRISPR gene editing has held the promise of curing most of the over 6,000 known genetic diseases. Now it’s being put to the test. Read more in ScienceNews
Author Archives: biocon
Measles is now resurgent in the United States and many other countries. Historical amnesia is partly to blame. Read more in National Geographic
Amid unrelenting chaos and violence, scientists and doctors in the Democratic Republic of Congo have been running a clinical trial of new drugs to try to combat a year-long Ebola outbreak. Read more in wired.com
Half of all Ebola spillover events—where the deadly virus jumps from wildlife to people—go undetected, warns new research from the University of Cambridge. Read more in laboratoryequipment.com
Novartis dismissed the top two scientists at its gene therapy division shortly after CEO Vas Narasimhan learned of internal data falsification that has since snowballed into a damaging scandal, a person familiar with the situation said Wednesday. Read more in statnews.com
Daniela Salvatori (recently appointed as Professor at the Faculty of Veterinary Medicine at Utrecht University and Central Animal Facility, LUMC) and Beerend Hierck (Anatomy teacher LUMC) have received a 22k grant from the Gratama foundation. Their research aims to develop dynamic holographic 3D models. Read more in Utrecht University News
Once, a diagnosis of extensively drug-resistant TB meant quick death. A three-drug regimen cures most patients in just months. Read more in nytimes.com
California wants to make it clear that tinkering with your own genes is a “don’t try this at home” sort of thing. Read more in vox.com
Ebola may soon be a “preventable and treatable” disease after a trial of two drugs showed significantly improved survival rates, scientists have said. Read more in bbc.com
Microbes that dwell in nutrient-poor waters use a photopigment called retinal to harvest energy from sunshine at levels at least equal to those stored by chlorophyll-based systems. Read more in the-scientist.com